Neogen Chemicals Share Price Today (NEOGEN)
TODAY IN ONE LINE
NEOGEN rose 1.8% on average volume, outperforming Nifty's 0.3% move, supported by recent strong earnings.
With a market cap of ₹5,540.41 Cr., it trades at a P/E of 150.45. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
Neogen Chemicals flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Earnings GrowthEPS (TTM) grew by a solid 375.9% YoY
- ●Quarterly OutperformanceLatest quarter Sales up 21.6% and Profit up 23.7%
- ●Healthy Operating MarginsOPM is structurally strong at 15.9%
- ●High Promoter HoldingPromoters hold 51.2% skin-in-the-game
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.02x
Red Flags
- ●Poor Capital ReturnsLow ROE of 3.6%
- ●Expensive ValuationTrading at a high P/E ratio of 184.3x
- ●FII SellingFII holding decreased by 2.20% QoQ
- ●Rising Receivables vs SalesReceivables grew 70.1% outpacing sales growth of 12.6%
- ●Promoter Pledging DetectedPledge activity recorded on 30-Mar-2026 19:48
Latest Neogen Chemicals News
What changed recently?
Recent events, corporate actions, and announcements.
Neogen Chemicals Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Neogen Chemicals Limited, framed against the sector median so the premium or discount is obvious at a glance.
Neogen Chemicals Limited trades at a P/E of 150.45× and P/B of 6.44×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
Neogen Chemicals Limited technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Neogen Chemicals Limited — derived from the live tape, not yesterday's close.
Neogen Chemicals Limited last traded at ₹2,023.1 with an intraday range of ₹2,000.6–₹2,075 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹2023.10| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 2214.00 | +190.90 | +9.44% |
| R3 | 2139.60 | +116.50 | +5.76% |
| R2 | 2107.30 | +84.20 | +4.16% |
| R1 | 2065.20 | +42.10 | +2.08% |
| PIVOT | 2032.90 | 9.80 | 0.48% |
| CURRENT | 2023.10 | — | — |
| S1 | 1990.80 | -32.30 | -1.60% |
| S2 | 1958.50 | -64.60 | -3.19% |
| S3 | 1916.40 | -106.70 | -5.27% |
| S4 | 1842.00 | -181.10 | -8.95% |
NEOGEN is trading Below CPR, indicating Bearishness
CPR is Average
Day's range: ₹2026–₹2075
Trading Inside opening range
Neogen Chemicals Limited financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for Neogen Chemicals Limited — consolidated or standalone — with margins, YoY growth and key ratios inline.
Neogen Chemicals Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹5,540.41 Cr. and reported EPS of ₹10.93.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 778 | 862 ▲ 10.9% |
| Sales Growth YoY %Derived | 12.58% | 10.85% |
| Other Income | 4 | 6 ▲ 53.1% |
| Total Income | 782 | 868 ▲ 11.1% |
| 423 | 466 ▲ 10.3% | |
| Gross ProfitDerived | 355 | 396 ▲ 11.6% |
| Gross Margin %Derived | 45.59% | 45.88% |
| 218 | 258 ▲ 18.2% | |
| EBITDA (Operating Profit)Derived | 136 | 138 ▲ 0.9% |
| OPM %Derived | 17.53% | 15.96% |
| 62 | 103 ▲ 65.0% | |
| Profit Before Tax (PBT) | 50 | 41 ▼ 17.8% |
| 15 | 12 ▼ 19.6% | |
| Effective Tax %Derived | 30.68% | 30.01% |
| Total Profit for Period | 35 | 29 ▼ 17.5% |
| Net Profit (Owner's PAT)Derived | 35 | 29 ▼ 17.5% |
| Net Profit Margin %Derived | 4.48% | 3.34% |
| PAT Growth YoY %Derived | -2.30% | -17.46% |
| Earnings Per Share (EPS ₹) | 13.20 | 10.90 ▼ 17.4% |
| Diluted Shares Outstanding (Cr) | 3 | 3 ▲ 0.0% |
| Share of Profit from Associates/JVs | 0 | — ▼ 100.0% |
| Other Comprehensive Income (Net of Tax) | -0 | 1 ▲ 275.0% |
| Total Expenses (incl. D&A & Interest) | 732 | 827 ▲ 13.0% |
| Material Cost % of RevenueDerived | 65.09% | 74.03% |
| Employee Cost % of RevenueDerived | 8.34% | 10.45% |
| Other Cost % of RevenueDerived | 19.72% | 19.47% |
| Interest Coverage (x)Derived | 2.24x | 1.47x |
| Period | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 239 | 306 ▲ 28.1% | 336 ▲ 9.9% | 487 ▲ 44.8% | 686 ▲ 40.8% | 691 ▲ 0.7% | 778 ▲ 12.6% | 862 ▲ 10.9% | |
| Sales Growth YoY %Derived | — | 28.05% | 9.90% | 44.84% | 40.83% | 0.65% | 12.58% | 10.85% | |
| Other Income | 1 | 0 ▼ 80.4% | 0 ▲ 39.2% | 1 ▲ 674.8% | 4 ▲ 315.9% | 7 ▲ 67.9% | 4 ▼ 46.3% | 6 ▲ 53.1% | |
| Total Income | 240 | 306 ▲ 27.8% | 337 ▲ 9.9% | 488 ▲ 45.1% | 691 ▲ 41.4% | 698 ▲ 1.1% | 782 ▲ 12.0% | 868 ▲ 11.1% | |
141 | 184 ▲ 30.9% | 198 ▲ 7.3% | 275 ▲ 39.1% | 389 ▲ 41.3% | 382 ▼ 1.5% | 423 ▲ 10.6% | 466 ▲ 10.3% | ||
| Gross ProfitDerived | 98 | 122 ▲ 24.1% | 139 ▲ 13.7% | 212 ▲ 53.0% | 298 ▲ 40.2% | 308 ▲ 3.5% | 355 ▲ 15.0% | 396 ▲ 11.6% | |
| Gross Margin %Derived | 41.15% | 39.86% | 41.25% | 43.57% | 43.38% | 44.62% | 45.59% | 45.88% | |
55 | 64 ▲ 16.4% | 74 ▲ 16.3% | 126 ▲ 68.9% | 186 ▲ 48.0% | 198 ▲ 6.5% | 218 ▲ 10.1% | 258 ▲ 18.2% | ||
| EBITDA (Operating Profit)Derived | 43 | 58 ▲ 33.7% | 64 ▲ 10.9% | 87 ▲ 34.5% | 112 ▲ 28.9% | 110 ▼ 1.4% | 136 ▲ 23.9% | 138 ▲ 0.9% | |
| OPM %Derived | 18.16% | 18.96% | 19.13% | 17.77% | 16.27% | 15.93% | 17.53% | 15.96% | |
15 | 17 ▲ 16.1% | 21 ▲ 19.6% | 31 ▲ 48.9% | 45 ▲ 46.7% | 65 ▲ 43.8% | 62 ▼ 4.2% | 103 ▲ 65.0% | ||
| Profit Before Tax (PBT) | 29 | 41 ▲ 40.5% | 44 ▲ 6.6% | 57 ▲ 29.8% | 71 ▲ 24.7% | 53 ▼ 25.9% | 50 ▼ 5.0% | 41 ▼ 17.8% | |
8 | 12 ▲ 49.7% | 13 ▲ 3.6% | 12 ▼ 3.4% | 21 ▲ 69.3% | 17 ▼ 18.7% | 15 ▼ 10.5% | 12 ▼ 19.6% | ||
| Effective Tax %Derived | 28.40% | 30.27% | 29.40% | 21.87% | 29.69% | 32.55% | 30.68% | 30.01% | |
| Total Profit for Period | 21 | 29 ▲ 36.8% | 31 ▲ 9.3% | 45 ▲ 42.4% | 50 ▲ 12.0% | 36 ▼ 28.7% | 35 ▼ 2.3% | 29 ▼ 17.5% | |
| Net Profit (Owner's PAT)Derived | 21 | 29 ▲ 36.8% | 31 ▲ 9.3% | 45 ▲ 42.4% | 50 ▲ 12.0% | 36 ▼ 28.7% | 35 ▼ 2.3% | 29 ▼ 17.5% | |
| Net Profit Margin %Derived | 8.76% | 9.36% | 9.31% | 9.16% | 7.28% | 5.16% | 4.48% | 3.34% | |
| PAT Growth YoY %Derived | — | 36.80% | 9.34% | 42.44% | 11.97% | -28.66% | -2.30% | -17.46% | |
| Earnings Per Share (EPS ₹) | 8.98 | 12.28 ▲ 36.7% | 13.43 ▲ 9.4% | 17.90 ▲ 33.3% | 20.04 ▲ 12.0% | 13.51 ▼ 32.6% | 13.20 ▼ 2.3% | 10.90 ▼ 17.4% | |
| Diluted Shares Outstanding (Cr) | 2 | 2 ▲ 0.0% | 2 ▲ 0.0% | 2 ▲ 6.9% | 2 ▲ 0.0% | 3 ▲ 5.8% | 3 ▲ 0.0% | 3 ▲ 0.0% | |
| Share of Profit from Associates/JVs | — | — | 0 | 0 ▼ 53.7% | 0 ▼ 44.4% | 0 ▲ 80.0% | 0 ▲ 11.1% | — ▼ 100.0% | |
| Other Comprehensive Income (Net of Tax) | 0 | -1 ▼ 615.6% | 0 ▲ 110.9% | -0 ▼ 587.8% | 0 ▲ 200.0% | -1 ▼ 314.3% | -0 ▲ 26.7% | 1 ▲ 275.0% | |
| Total Expenses (incl. D&A & Interest) | 210 | 265 ▲ 26.1% | 293 ▲ 10.4% | 431 ▲ 47.4% | 620 ▲ 43.6% | 646 ▲ 4.2% | 732 ▲ 13.3% | 827 ▲ 13.0% | |
| Material Cost % of RevenueDerived | 66.78% | 74.39% | 53.73% | 70.55% | 70.72% | 68.71% | 65.09% | 74.03% | |
| Employee Cost % of RevenueDerived | 4.67% | 5.63% | 5.97% | 6.46% | 6.82% | 8.98% | 8.34% | 10.45% | |
| Other Cost % of RevenueDerived | 18.32% | 15.26% | 16.16% | 19.33% | 20.29% | 19.71% | 19.72% | 19.47% | |
| Interest Coverage (x)Derived | 3.40x | 4.43x | 4.17x | 3.93x | 3.30x | 2.07x | 2.24x | 1.47x |
Neogen Chemicals segment analysis : revenue and profit mix.
Disclosed business segments at Neogen Chemicals with their share of revenue and profit, switchable between consolidated and standalone reporting.
Neogen Chemicals discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Neogen Chemicals Limited.
Our AI distills the core fundamental drivers supporting Neogen Chemicals Limited, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
Neogen Chemicals Limited's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Strong promoter holding at 51.22% signals management confidence and long-term commitment.
Operating margin of 12.73% exceeds peer median, demonstrating pricing power in specialty chemicals.
TTM revenue grew 21.6% YoY, reflecting robust top-line expansion in specialty chemicals sector.
Established player since 1989 with exports to 31+ countries, demonstrating global market presence.
Latest quarterly EPS surged 372.6% YoY, showcasing exceptional earnings momentum from depressed base.
Key Risks.
Stock P/E of 184.31x signals severe overvaluation relative to earnings capacity and peer multiples.
Operating cash flow per share negative at ₹-84.54, reflecting persistent cash burn despite profitability.
Net profit margin of 3.33% is lowest among peers, indicating weak profitability conversion efficiency.
Latest quarterly PAT declined 10.6% YoY despite revenue growth, signaling margin compression pressure.
EV/EBITDA of 55.78x far exceeds peer median 15.90x, indicating stretched valuation multiples.
Flip Conditions.
Valuation risk. a P/E above 196 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 2.21. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
Neogen Chemicals Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Neogen Chemicals Limited is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
Neogen Chemicals Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Neogen Chemicals Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
- 1Pick how to scan. Detection sets sensitivity — Daily (standard) → Weekly (big swings). History sets how far back to look.
- 2Read the summary. The tiles at the top give the current read: net bias, the strongest pattern, and the one nearest to triggering.
- 3Scan the list. Use the Actionable, Watchlist, and History tabs to browse patterns. Click a pattern card to focus it.
- 4Inspect on the chart. Focusing draws the pattern’s pivots plus its break (blue), target (amber) and invalidation lines.
- 5Filter to what matters. Use the status controls (Confirmed, Forming, Invalidated) to hide noise and find exactly what you are looking for.
Pattern history — every completed pattern and its outcome
Neogen Chemicals Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Neogen Chemicals Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Neogen Chemicals Limited stood at 41.8% of traded volume, against a 20-day average of 38.7%.
Neogen Chemicals announcements: results, concalls, ratings, M&A.
Filings Neogen Chemicals sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Neogen Chemicals files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 242 documents below.
Monitoring Agency Report
(Revised) Statement of deviation or variation in utilisation of funds raised through Preferential Issue for the quarter ended June 30, 2026 and…
Statement of deviation(s) or variation(s) under Reg. 32
Neogen Chemicals Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
Monitoring Agency Report
Monitoring Agency Report issued by CRISIL Ratings Limited.
Statement of deviation(s) or variation(s) under Reg. 32
Neogen Chemicals Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
Qualified Institutional Placement
Neogen Chemicals Limited has informed the Exchange about Qualified Institutional Placement and other permissible modes for raising of funds.
Investor decks & rating reports.
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation
Neogen Chemicals dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Neogen Chemicals has declared, sequenced by announce and record date.
Neogen Chemicals corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
Neogen Chemicals insider trading: promoter and management activity.
Promoter, director and designated-employee transactions in Neogen Chemicals as reported to SEBI — buying and selling signals from the people who know the business best.
Neogen Chemicals insider activity below tracks 21 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| CADAMBA SOLUTIONS PRIVATE LIMITED | Insider | 18 Apr 2026 | buy | +10.00 L | ₹161 Cr. | ₹1,610.00 |
| CADAMBA SOLUTIONS PRIVATE LIMITED | Insider | 18 Apr 2026 | buy | +10.00 L | ₹161 Cr. | ₹1,610.00 |
| CADAMBA SOLUTIONS PRIVATE LIMITED | Insider | 18 Apr 2026 | buy | +10.00 L | ₹161 Cr. | ₹1,610.00 |
| CADAMBA SOLUTIONS PRIVATE LIMITED | Insider | 18 Apr 2026 | buy | +10.00 L | ₹161 Cr. | ₹1,610.00 |
| CADAMBA SOLUTIONS PRIVATE LIMITED | Insider | 18 Apr 2026 | buy | +10.00 L | ₹161 Cr. | ₹1,610.00 |
| CADAMBA SOLUTIONS PRIVATE LIMITED | Insider | 18 Apr 2026 | buy | +10.00 L | ₹161 Cr. | ₹1,610.00 |
| CADAMBA SOLUTIONS PRIVATE LIMITED | Insider | 18 Apr 2026 | buy | +10.00 L | ₹161 Cr. | ₹1,610.00 |
| CADAMBA SOLUTIONS PRIVATE LIMITED | Insider | 18 Apr 2026 | buy | +10.00 L | ₹161 Cr. | ₹1,610.00 |
| HARIN HARIDAS KANANI | Insider | 13 Apr 2026 | buy | +20.19 L | — | — |
| HARIN HARIDAS KANANI | Insider | 30 Mar 2026 | buy | +13.19 L | — | — |
About Neogen Chemicals Limited: business, sector, key facts.
What Neogen Chemicals Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Neogen Chemicals Limited operates in the Specialty Chemicals industry under the Chemicals sector, listed as NSE: NEOGEN, BSE: 542665.
Neogen Chemicals Limited is an Indian specialty chemical manufacturer and supplier, established in 1989 and headquartered in Thane. Their primary business revolves around the production and sale of a diverse range of chemical compounds, catering to a broad spectrum of industrial sectors.
A significant portion of Neogen's product portfolio centers on organobromine compounds. This encompasses a wide variety of alkyl bromides, dibromoalkanes, and other bromine-based derivatives. They also offer specialty chloro compounds, organolithium compounds, and inorganic chemicals such as bromine compounds and lithium salts. The company's expertise extends to Grignard reagents and advanced intermediates, highlighting their proficiency in complex chemical synthesis.
Beyond the specific chemical compounds, Neogen provides a comprehensive suite of chemical services. This includes custom synthesis tailored to client-specific needs, along with contract manufacturing services for larger-scale production requirements. Their expertise covers various chemical reactions such as alkylation, acylation, and halogenation, showcasing their versatile capabilities in chemical transformation.
The company's diverse clientele spans a wide array of industries. Key sectors served include pharmaceuticals, agrochemicals, engineering, electronics, polymers, water treatment, construction, aroma chemicals, flavors and fragrances, and specialty polymers. Their global reach is demonstrated by exports to 31 countries, solidifying their position as a significant player in the international specialty chemicals market.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Aarti Industries (AARTIIND) Share PricePeer
- Aarti Surfactants (AARTISURF) Share PricePeer
- Archean Chemical Industries (ACI) Share PricePeer
- Aether Industries (AETHER) Share PricePeer
- Alkali Metals (ALKALI) Share PricePeer
- Other overvalued NSE stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Neogen Chemicals Limited (NEOGEN).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Neogen Chemicals Limited (NEOGEN)?
The current share price of Neogen Chemicals Limited (NEOGEN) is ₹2,023.1. Today, the stock has gained by ₹35.00 (1.76%), trading in a range of ₹2,000.6 to ₹2,075. The stock opened at ₹2,026 with a trading volume of 1,74,854 shares.
02Is Neogen Chemicals Limited stock a good investment for long-term?
Neogen Chemicals Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹5,540.41 crores, P/E ratio of 150.45, ROE of 3.58%, and ROCE of 6.46%. The dividend yield stands at 0.05%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Neogen Chemicals Limited stock?
The 52-week high price of Neogen Chemicals Limited (NEOGEN) is ₹2,374, while the 52-week low is ₹966.7. Currently trading at ₹2,023.1, the stock is 75.1% away from its 52-week low and 14.8% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Neogen Chemicals Limited stock at the current price?
Whether to buy Neogen Chemicals Limited stock at ₹2,023.1 depends on multiple factors. The stock is currently trading with a P/E ratio of 150.45 and P/B ratio of 6.44. Today's performance shows a gain of 1.76%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Neogen Chemicals Limited and when is the next dividend?
Neogen Chemicals Limited offers a dividend yield of 0.05%, which means for every ₹100 invested at the current price of ₹2,023.1, you can expect to receive approximately ₹0.05 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Neogen Chemicals Limited?
Neogen Chemicals Limited's key financial metrics include: P/E Ratio: 150.45, P/B Ratio: 6.44, ROE: 3.58%, ROCE: 6.46%, Dividend Yield: 0.05%, EPS: ₹10.93, Book Value: ₹309.59, and Debt-to-Equity: 1.71. The company's market cap stands at ₹5,540.41 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Neogen Chemicals Limited stock performing today in the market?
Neogen Chemicals Limited stock opened at ₹2,026 and is currently trading at ₹2,023.1, showing a gain of ₹35.00 (1.76%). The intraday high is ₹2,075 and low is ₹2,000.6. The trading volume stands at 1,74,854 shares, indicating moderate market participation today.
08What is the P/E ratio of Neogen Chemicals Limited and what does it indicate?
Neogen Chemicals Limited has a Price-to-Earnings (P/E) ratio of 150.45, which means investors are willing to pay ₹150.45 for every ₹1 of earnings. With an EPS of ₹10.93, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Neogen Chemicals Limited (NEOGEN) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.